What Drove Bath & Body Works' Q1 Margins Despite Tariff Pressures?

Bath & Body Works (BBWI) reported a strong start to fiscal 2025, with Q1 gross profit up 6.6% to $646 million and gross margin increasing 160 bps to 45.4%, driven by mix-adjusted AUR growth and cost optimization. Operating income rose 11.8% to $209 million, with operating margin expanding 120 bps to 14.7%, despite tariff pressures which the company mitigated through supply chain agility and cost management. Looking ahead, BBWI anticipates a Q2 gross margin of approximately 41%, flat compared to the prior year, reflecting the ongoing impact of tariffs.

Analysis

Bath & Body Works (BBWI) reported a robust start to fiscal 2025, with first-quarter gross profit increasing 6.6% year-over-year to $646 million, and gross margin expanding by 160 basis points to 45.4%. This margin improvement was primarily driven by a 100-basis-point rise in merchandise margin, attributed to low single-digit growth in mix-adjusted average unit retail (AUR) achieved through enhanced product mix and value engineering, rather than simple price hikes. Further contributing to margin strength were approximately 50 basis points from favorable buying and occupancy leverage, as occupancy expenses remained flat despite net sales growth, and reduced depreciation expenses following a re-evaluation of store assets' useful life. Operational efficiencies were also realized from the strategic exit of a third-party fulfillment center. Consequently, operating income climbed 11.8% to $209 million, with the operating margin improving 120 basis points to 14.7%. The company successfully mitigated tariff pressures, stemming from its approximate 10% global spend exposure to China, through an agile, predominantly U.S.-based supply chain and proactive cost management. For the second quarter of fiscal 2025, BBWI anticipates a gross margin of around 41%, flat year-over-year, which incorporates expected ongoing tariff impacts and licensing expenses from collaborations. Despite these strong fundamentals and a favorable Zacks Value Score of A, the stock has declined 10.3% in the past three months, contrasting with the industry’s 3.7% growth, and trades at a forward 12-month price-to-sales ratio of 0.76, significantly below industry (1.64) and sector (1.58) averages.

Key Decisions for Investors

• Investors should assess whether the current forward price-to-sales ratio of 0.76, which is substantially below industry and sector averages, presents a compelling valuation opportunity given the strong Q1 operational performance and margin expansion.
• Monitor the company's success in achieving its Q2 gross margin target of approximately 41%, flat year-over-year, as this will be indicative of its continued ability to manage tariff impacts and integrate costs from strategic initiatives like high-profile collaborations.
• Consider the recent 10.3% stock price decline against the backdrop of positive Q1 results and operational efficiencies; this divergence warrants careful examination of market sentiment versus fundamental strength, especially in light of its Zacks Rank #3 (Hold) status.